Ellen Schlette
Abstract
This chapter covers chronic lymphocytic leukemia (CLL) and its variants as well as its lymph node counterpart, small lymphocytic lymphoma (SLL). The role of well-established and more experimental immunophenotypic and molecular biomarkers in predicting outcome and need for treatment in CLL/SLL is summarized.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This chapter covers chronic lymphocytic leukemia (CLL) and its variants as well as its lymph node counterpart, small lymphocytic lymphoma (SLL). The role of well-established and more experimental immunophenotypic and molecular biomarkers in predicting outcome and need for treatment in CLL/SLL is summarized.
Key concepts: Chronic lymphocytic leukemia, Medicine, Lymphoma, Lymph node, Leukemia, Cancer research, Oncology, Pathology